Skin Cancer and Dermatology

Welcome Message

It is our great pleasure to warmly welcome you to the International Conference on Skin Cancer and Dermatology, taking place on April 12–13, 2027, in Dubai, UAE. Under the inspiring theme, “Advancing Skin Health through Innovation, Precision, Prevention and Personalized Dermatological Care,” this international gathering brings together distinguished dermatologists, oncologists, surgeons, dermatopathologists, researchers, healthcare professionals, academics, and industry leaders from around the world.Skin cancer and dermatological disorders continue to present significant challenges to healthcare systems and communities worldwide. Rapid advances in diagnostic technologies, molecular medicine, artificial intelligence, immunotherapy, targeted treatments, digital dermatology, and personalized care are creating new opportunities to improve prevention, early detection, treatment, and patient outcomes.This conference provides an exceptional platform for exchanging scientific knowledge, presenting innovative research, discussing clinical experiences, and exploring emerging technologies shaping the future of dermatology. Through expert presentations, scientific discussions, interactive exchanges, and professional networking, participants will have valuable opportunities to learn from leading specialists and establish meaningful international collaborations.

Target Audience

The conference is designed for professionals, researchers, academics, and organizations working across dermatology, skin cancer, oncology, aesthetic medicine, pathology, surgery, and related healthcare disciplines.

• Dermatologists
• Dermatologic Surgeons
• Dermatopathologists
• Pathologists
• Plastic and Reconstructive Surgeons
• General Surgeons
• Radiation Oncologists
• Paediatric Dermatologists
• Cosmetic and Aesthetic Physicians
• Dermatology Researchers
• PhD Scholars and Research Students
• Pharmaceutical and Biotechnology Companies
• Medical Device Manufacturer
• Dermatology Technology Companies
• Laser and Energy-Based Device Companies
• Artificial Intelligence and Healthcare Technology Developers
• Medical Students
• Healthcare Administrators
• Hospital and Clinic Representatives
• Professional Medical Associations
• Government and Public Health Representatives
• Patient Advocacy and Skin Cancer Awareness Organizations

About The Conference

The International Conference on Skin Cancer and Dermatology will bring together dermatologists, oncologists, dermatopathologists, surgeons, researchers, healthcare professionals, and industry experts to explore the latest developments in skin health, dermatological diseases, and skin cancer care. “Advancing Skin Health through Innovation, Precision, Prevention and Personalized Dermatological Care,”Taking place on April 12–13, 2027, in Dubai, UAE, the conference will provide a global platform for scientific exchange, professional collaboration, and knowledge sharing.The conference will focus on advances in the prevention, early detection, diagnosis, treatment, and management of skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma. Participants will explore modern diagnostic approaches such as dermoscopy, digital skin imaging, dermatopathology, molecular diagnostics, and artificial intelligence-assisted detection.

Emerging therapeutic approaches will receive significant attention, including immunotherapy, targeted therapies, precision medicine, Mohs micrographic surgery, laser-based treatments, and innovative drug-delivery technologies. Discussions will also address treatment resistance, personalized cancer care, clinical decision-making, and strategies for improving long-term patient outcomes.Beyond skin cancer, the conference will cover a broad spectrum of dermatological conditions, including acne, rosacea, psoriasis, atopic dermatitis, paediatric skin disorders, hair and scalp diseases, nail disorders, skin infections, photodermatology, and dermatologic manifestations of systemic diseases. Cosmetic and aesthetic dermatology, skin rejuvenation, and energy-based technologies will also form important areas of discussion.

Benefits of Participating in the Conference

Participating in the International Conference on Skin Cancer and Dermatology offers valuable opportunities for professional learning, scientific exchange, and career development. Key benefits include:

• Certificate of Participation: Receive an official certificate recognizing your participation in the conference and your professional engagement.

• Latest Scientific Insights: Learn about recent developments in skin cancer diagnosis, dermatological treatments, precision medicine, immunotherapy, and emerging technologies.

• Expert Knowledge: Gain insights from experienced dermatologists, oncologists, researchers, surgeons, and other specialists working in the field.

• Research Exposure: Discover current research findings, innovative approaches, and emerging trends in dermatology and skin cancer care.

• Professional Networking: Connect with healthcare professionals, researchers, academics, students, and industry representatives from different countries.

• Knowledge Exchange: Share your experiences, ideas, clinical practices, and research interests with an international audience.

• Career Development: Expand your professional connections and discover potential opportunities for research collaborations, academic partnerships, and career growth.

• Innovation and Technology: Explore developments in artificial intelligence, digital dermatology, advanced imaging, laser technology, and personalized treatment.

• Interdisciplinary Learning: Understand how dermatology connects with oncology, pathology, surgery, genetics, immunology, technology, and other healthcare disciplines.

• International Exposure: Participate in a global scientific environment in Dubai, UAE, providing an opportunity to interact with professionals from diverse healthcare backgrounds.

• Inspiration for Future Research: Identify emerging challenges and research areas that can support new projects, collaborations, and scientific investigations.

• Enhanced Professional Profile: Active participation in an international scientific event can contribute to continued professional learning and strengthen your academic or professional profile.

Abstract Submission Guidelines :

Submit abstracts through the ABSTRACT SUBMISSION portal.

Abstracts must be written in English (250–300 words) and accompanied by a 100–120-word presenter biography.

Abstract submissions are welcome in all dermatology and skin cancer-related fields, including melanoma, non-melanoma skin cancers, dermatopa Abstract submissions are welcome in all dermatology and skin cancer-related fields, including melanoma, non-melanoma skin cancers, dermatopathology, dermoscopy, skin cancer diagnosis and treatment, immunotherapy, targeted therapies, surgical dermatology, cosmetic dermatology, pediatric dermatology, inflammatory skin diseases, photodermatology, laser dermatology, hair and scalp disorders, nail disorders, skin infections, teledermatology, artificial intelligence in dermatology, digital health, precision dermatology, and other related disciplines.thology, dermoscopy, skin cancer diagnosis and treatment, immunotherapy, targeted therapies, surgical dermatology, cosmetic dermatology, pediatric dermatology, inflammatory skin diseases, photodermatology, laser dermatology, hair and scalp disorders, nail disorders, skin infections, teledermatology, artificial intelligence in dermatology, digital health, precision dermatology, and other related disciplines.

Presenting authors should provide:

• Full Name
• Institutional Affiliation
• Country
• Phone Number
• Email Address
• Photograph

Co-authors should provide their full names and institutional affiliations.

All submissions will undergo peer review by the DERMATOLOGY MEET 2027 Scientific Review Committee. Accepted presenters must complete conference registration and pay the applicable registration fee. Please ensure all submitted information is accurate, as it will appear exactly as provided in the conference program and proceedings. Complete your registration using the Online Registration link.

Visa Guidelines – DERMATOLOGY MEET 2027

The organizing committee does not process visa applications but can provide supporting documents, including:

• Letter of Invitation
• Letter of Abstract Acceptance
• Registration Payment Receipt

Official invitation letters will be issued only after successful registration.

Participants may be required to submit:

• Passport Copy
• Date of Birth
• Residential Address
• Mobile Number
• Photograph

Sessions and Tracks

Track1: Skin Cancer

Skin cancer remains one of the most important areas of modern dermatology, requiring early recognition and effective intervention. This topic will explore current approaches to diagnosing melanoma and non-melanoma skin cancers. Discussions will focus on dermoscopy, biopsy techniques, digital imaging, and advanced diagnostic technologies. Participants will examine surgical, topical, radiation, and systemic treatment options. Emerging targeted therapies and immunotherapies will also be highlighted. The role of multidisciplinary cancer care in improving patient outcomes will be addressed. Special emphasis will be placed on early detection and personalized treatment strategies.

Innovations transforming skin cancer prevention, diagnosis, and treatment will also be explored.

• Early Detection and Screening of Skin Cancer
• Advanced Diagnostic and Imaging Techniques
• Personalized Treatment and Cancer Care

Track2: Melanoma

Melanoma is an aggressive form of skin cancer in which early diagnosis can significantly influence clinical outcomes. This topic will examine clinical examination, dermoscopy, digital monitoring, and molecular diagnostic approaches. Participants will explore risk factors associated with melanoma development and progression. Current surgical approaches and staging principles will be discussed. Advances in immunotherapy and targeted molecular treatments will be highlighted.Strategies for managing advanced and metastatic melanoma will also be reviewed. Artificial intelligence and image-analysis technologies are creating new opportunities for early recognition.Individualized approaches to melanoma prevention, diagnosis, and treatment will be emphasized.

• Melanoma Screening and Dermoscopic Diagnosis
• Immunotherapy and Targeted Treatment
• Advanced and Metastatic Melanoma Management

Track3: Non-Melanoma Skin Cancers

Non-melanoma skin cancers, particularly basal cell carcinoma and squamous cell carcinoma, represent a major dermatological burden. This topic will examine their clinical presentation, risk factors, diagnosis, and disease progression. Participants will discuss dermoscopic evaluation and appropriate biopsy techniques. Treatment options including excision, Mohs surgery, cryotherapy, topical therapy, and photodynamic therapy will be explored. The role of radiation and systemic treatments in advanced disease will also be considered. Special attention will be given to high-risk tumors and recurrent lesions. Prevention strategies and long-term surveillance will form an important part of the discussion.Practical approaches to improving early diagnosis and patient outcomes will be highlighted.

• Basal Cell Carcinoma
• Squamous Cell Carcinoma
• High-Risk and Recurrent Skin Cancers

Track4: Dermoscopy and Advanced Skin Imaging

Dermoscopy has become an essential tool for evaluating suspicious pigmented and non-pigmented skin lesions. This topic will explore dermoscopic patterns associated with melanoma and other dermatological conditions. Participants will learn about digital dermoscopy and sequential monitoring of high-risk lesions. Advanced imaging technologies can improve diagnostic confidence and reduce unnecessary biopsies. The role of total-body photography in patients with multiple nevi will also be discussed. Artificial intelligence-assisted image analysis is emerging as an important diagnostic support tool. Opportunities and limitations of automated image interpretation will be examined.Emphasis will be placed on integrating imaging technologies with clinical expertise.

• Digital Dermoscopy and Lesion Monitoring
• Total-Body Photography
• AI-Assisted Skin Imaging

Track5: Artificial Intelligence in Dermatology

Artificial intelligence is rapidly transforming dermatological diagnosis, imaging, research, and patient care. This topic will examine machine-learning applications for identifying suspicious skin lesions.AI-assisted image analysis may support clinicians in differentiating benign lesions from malignancies.Discussions will address digital dermatology, automated screening, and clinical decision-support systems. Participants will also explore challenges related to data quality, algorithmic bias, and diagnostic reliability. The potential integration of AI into teledermatology platforms will be considered. Ethical, regulatory, and patient-privacy issues surrounding AI applications will be highlighted. Responsible AI can complement clinical expertise while supporting more efficient dermatological care.

• AI-Based Skin Cancer Detection
• Machine Learning and Digital Dermatology
• Ethical and Regulatory Challenges of AI

Track6: MohsMicrographic Surgery and Surgical Dermatology

Mohs micrographic surgery provides tissue-sparing treatment for selected cutaneous malignancies.This topic will examine indications, patient selection, surgical techniques, and reconstruction principles. Participants will discuss the advantages of complete margin assessment during cancer surgery. The management of tumours in cosmetically and functionally sensitive anatomical areas will be emphasized. Reconstructive options following tumour removal will also be explored.Advances in surgical planning and intraoperative assessment will be discussed.Recurrence prevention and long-term follow-up will receive particular attention.Clinical case-based approaches will demonstrate the importance of specialized dermatologic surgery.

• Mohs Micrographic Surgery
• Surgical Reconstruction and Wound Management
• Complex and High-Risk Skin Tumour Surgery

Track7: Immunotherapy and Targeted Therapies in Skin Cancer

The development of immunotherapy and targeted treatment has significantly expanded options for advanced skin cancers. This topic will explore immune checkpoint inhibitors and molecularly targeted therapies. Participants will examine treatment strategies for advanced melanoma and selected non-melanoma skin cancers. The importance of tumour biology and molecular profiling in treatment selection will be discussed. Potential treatment responses, resistance mechanisms, and adverse effects will also be reviewed. Combination treatment strategies represent an important area of ongoing research. Personalized oncology and precision dermatology are creating new opportunities for individualized treatment. Future therapeutic approaches aimed at improving durable responses will also be considered.

• Immune Checkpoint Inhibitors
• Molecularly Targeted Therapies
• Treatment Resistance and Combination Therapies

Track8: Photo dermatology and UV-Related Skin Disorders

Ultraviolet radiation is a major environmental factor contributing to photoaging and skin cancer development. This topic will examine the effects of UVA and UVB exposure on the skin.Participants will explore photodermatoses, photosensitivity disorders, and chronic sun-induced skin changes. The relationship between cumulative UV exposure and skin malignancies will be discussed.Photo protection strategies, sunscreens, protective clothing, and behavioural interventions will be highlighted. The role of patient education in reducing preventable UV-related disease will be emphasized. Emerging approaches to photoprotection and monitoring of high-risk individuals will be considered. Evidence-based strategies for maintaining long-term skin health will be promoted.

• UV Radiation and Photo aging
• Photosensitivity Disorders
• Photo protection and Skin Cancer Prevention

Track9: Cosmetic Dermatology and Skin Rejuvenation

Cosmetic dermatology combines medical knowledge with technologies designed to improve skin appearance and quality. This topic will explore contemporary approaches to skin rejuvenation and aesthetic dermatology. Areas of interest will include chemical peels, laser treatments, injectable procedures, and energy-based technologies. Participants will examine treatment selection according to skin type, age, and individual concerns. The importance of patient assessment and realistic treatment expectations will be emphasized. Safety, adverse effects, and appropriate management of complications will be discussed. Emerging minimally invasive technologies are creating new possibilities for personalized aesthetic care. Safe and evidence-informed approaches to achieving natural-looking results will be highlighted.

• Non-Invasive Skin Rejuvenation
• Chemical Peels and Injectable Treatments
• Emerging Aesthetic Technologies

Track10: Laser and Energy-Based Dermatology

Laser technology has become an important component of modern dermatological and aesthetic practice. This topic will examine lasers and energy-based devices used for pigmentation, vascular lesions, scars, and skin rejuvenation. Participants will explore different treatment principles and device selection strategies. The importance of skin type, treatment parameters, and patient safety will be emphasized. Fractional technologies and other minimally invasive approaches will also be discussed. Adverse effects, contraindications, and complication management will be examined. Advances in device technology are enabling increasingly precise and individualized treatments. Future developments in energy-based dermatology will also be considered.

• Laser Treatment for Pigmentation and Vascular Lesions
• Fractional and Resurfacing Technologies
• Laser Safety and Complication Management

Track11: Acne,Rosacea and Common Inflammatory Skin Disorders

Acne and rosacea are common chronic dermatological conditions that can significantly affect quality of life. This topic will explore their pathophysiology, clinical diagnosis, and modern treatment approaches. Participants will review topical and systemic therapies used across different disease severities. The management of acne scarring and post-inflammatory changes will also be discussed.For rosacea, emphasis will be placed on identifying triggers and selecting individualized treatment strategies. Emerging therapies and combination treatment approaches will be examined.Psychological and social effects associated with visible inflammatory skin conditions will be highlighted. Long-term disease control and patient-centred dermatological care will remain key priorities.

• Acne Diagnosis and Advanced Treatment
• Acne Scarring and Post-Inflammatory Changes
• Rosacea Management and Emerging Therapies

Track12: Psoriasis and Atopic Dermatitis: Modern Therapeutic Strategies

Psoriasis and atopic dermatitis are chronic inflammatory diseases requiring individualized long-term management. This topic will examine current understanding of immune mechanisms underlying these conditions. Participants will discuss topical treatments, phototherapy, systemic therapies, and biologic agents. Advances in targeted therapies have expanded treatment options for moderate-to-severe disease. Treatment selection according to disease severity, comorbidities, and patient preferences will be explored. The importance of monitoring treatment response and safety will be emphasized.Quality of life and the psychosocial burden of chronic skin disease will also be addressed.Future developments in precision treatment and personalized dermatology will be highlighted.

• Biologic and Targeted Therapies
• Phototherapy and Systemic Treatment
• Personalized Management of Chronic Inflammatory Skin Disease

Track13: Paediatric Dermatology and Childhood Skin Disorders

Paediatric dermatology requires specialized approaches because children's skin differs in structure and function from adult skin. This topic will explore common inflammatory, infectious, genetic, and congenital skin disorders in children. Participants will discuss approaches to diagnosing challenging paediatric dermatological conditions. Atopic dermatitis, acne, birthmarks, vascular anomalies, and inherited disorders will be considered. The safe selection and dosing of dermatological treatments in children will be emphasized. The psychological impact of visible skin conditions on children and families will also be addressed. Early recognition of serious or potentially life-threatening disorders will be highlighted. Family-centred and age-appropriate dermatological care will be promoted.

• Common Paediatric Skin Disorders
• Congenital and Genetic Skin Conditions
• Paediatric Dermatological Treatments and Safety

Track14: Dermatopathology and Molecular Diagnosis

Accurate pathological diagnosis is fundamental to the management of skin cancer and complex dermatological diseases. This topic will explore the relationship between clinical findings, dermoscopy, histopathology, and molecular testing. Participants will review important histological features of common skin malignancies. The role of immunohistochemistry in challenging diagnostic cases will be discussed. Molecular techniques are increasingly contributing to tumour classification and treatment planning. Clinic pathological correlation will be emphasized as an essential component of accurate diagnosis. Digital pathology and artificial intelligence may further enhance diagnostic workflows. Advanced pathology approaches can support personalized and precision-based dermatological care.

• Histopathological Diagnosis of Skin Tumors
• Immunohistochemistry and Molecular Testing
• Digital Pathology and Precision Dermatology

Track15: Teledermatology and Digital Dermatology

Digital healthcare is expanding access to dermatological expertise across geographical and healthcare settings. This topic will explore teleconsultation, store-and-forward dermatology, and remote skin monitoring. Participants will examine the role of digital images in evaluating skin lesions and chronic disorders. Teledermatology can support early referral and improve access to specialist care. The integration of artificial intelligence into digital dermatology will also be discussed. Challenges involving image quality, privacy, communication, and diagnostic limitations will be considered. Digital platforms may also support long-term monitoring and patient education. The future of connected and technology-enabled dermatological practice will be explored.

• Remote Dermatological Consultation
• Digital Imaging and Remote Skin Monitoring
• AI and Technology in Teledermatology

Track16: Skin Infections and Emerging Dermatological Diseases

Infectious skin diseases continue to represent a significant clinical challenge worldwide. This topic will cover bacterial, viral, fungal, and parasitic infections affecting the skin. Participants will explore approaches to clinical diagnosis and laboratory confirmation. Antimicrobial resistance is creating increasing challenges in the management of skin infections. Emerging infections and changing patterns of dermatological disease will also be examined. Appropriate antimicrobial use and infection-control strategies will be discussed. Special attention will be given to infections affecting immune compromised and vulnerable patients. New diagnostic technologies and therapeutic approaches will be highlighted.

• Bacterial, Viral and Fungal Skin Infections
• Antimicrobial Resistance in Dermatology
• Emerging and Re-Emerging Dermatological Infections

Track17: Dermatologic Manifestations of Systemic Diseases

The skin can provide important clinical clues to underlying systemic disorders. This topic will explore dermatological manifestations associated with autoimmune, endocrine, metabolic, and infectious diseases. Participants will examine how cutaneous findings can contribute to early systemic diagnosis.Conditions involving connective tissue, vasculature, internal organs, and immune dysfunction will be discussed. The importance of collaboration between dermatologists and other medical specialties will be emphasized. Case-based learning will demonstrate the diagnostic value of recognizing characteristic skin findings. Early identification of systemic disease can improve referral and treatment decisions. An integrated approach to dermatology and multisystem patient care will be promoted.

• Autoimmune and Connective Tissue Disorders
• Endocrine and Metabolic Skin Manifestations
• Cutaneous Signs of Systemic Disease

Track18: Hair and ScalpDisorders

Hair and scalp disorders can result from inflammatory, hormonal, genetic, nutritional, and autoimmune factors. This topic will explore the diagnosis and management of common forms of hair loss and scalp disease. Participants will discuss alopecia areata, androgenetic alopecia, scarring alopecias, and other conditions. Trichoscopy and other diagnostic techniques can improve assessment of hair and scalp disorders. Medical and procedural treatment options will be reviewed according to the underlying cause. The psychological and social consequences of hair loss will also be addressed. Emerging therapies and regenerative approaches represent areas of growing clinical interest. Accurate diagnosis and individualized long-term management will remain central to effective care.

• Alopecia Areata and Autoimmune Hair Disorders
• Androgenetic and Scarring Alopecias
• Trichoscopy and Regenerative Hair Therapies

Track19: Future Directions in Dermatology and Personalized Skin Care

The future of dermatology is being shaped by precision medicine, digital technologies, artificial intelligence, and advanced therapeutics. This topic will explore emerging innovations likely to influence clinical dermatology in the coming years. Personalized treatment approaches based on genetics, biomarkers, skin characteristics, and patient preferences will be discussed. Novel drug-delivery systems and regenerative technologies may expand therapeutic possibilities.AI-assisted diagnostics and remote monitoring is expected to further transform clinical workflows. Ethical, regulatory, and accessibility challenges associated with emerging technologies will also be considered. Collaboration between clinicians, researchers, technology developers, and patients will be emphasized. The future will focus on safer, more precise, innovative, and patient-centered dermatological care.

• Precision Medicine and Personalized Dermatology
• Regenerative Medicine and Novel Therapies
• Future Applications of AI and Digital Health

Market Analysis

The global skin cancer market was valued at approximately USD 10.61 billion in 2024 and is projected to reach USD 20.48 billion by 2033, expanding at a compound annual growth rate (CAGR) of approximately 7.6% during the forecast period. The increasing incidence of melanoma and non-melanoma skin cancers, rising ultraviolet (UV) exposure, aging populations, greater awareness of skin cancer screening, and improvements in early detection are driving demand for advanced dermatological diagnosis and treatment.Rapid advancements in dermoscopy, digital skin imaging, artificial intelligence-assisted diagnosis, molecular testing, immunotherapy, targeted therapies, Mohs micrographic surgery, and precision medicine are transforming the management of skin cancer and other dermatological conditions. The global skin cancer diagnostics market alone was estimated at approximately USD 9.58 billion in 2024 and is projected to reach USD 15.67 billion by 2033, growing at a CAGR of approximately 5.7%.

The broader dermatology drugs market further demonstrates strong growth potential, increasing from approximately USD 21.43 billion in 2024 to USD 56.27 billion by 2033, representing a CAGR of approximately 11.32%. This growth is supported by increasing demand for advanced treatments for skin diseases, biologic therapies, targeted medicines, and personalized dermatological care.North America currently represents the largest regional market for skin cancer and skin cancer diagnostics, while Asia-Pacific is among the fastest-growing regions, supported by increasing healthcare investment, improving diagnostic infrastructure, rising awareness, and a growing need for specialized dermatological services.

Participation and Presentation

Oral Presentation

• Oral presentations are open to research-based, clinical, educational, and professional topics related to skin cancer and dermatology.
• Presenters can share original research, clinical experiences, innovative treatments, diagnostic approaches, and emerging technologies.
• The opportunity is open to dermatologists, oncologists, surgeons, researchers, academicians, and healthcare professionals.
• Presentations will encourage scientific discussion and exchange of knowledge with an international audience.
• Participants can gain professional visibility while connecting with specialists from different countries.

Presentation: 20–25 minutes + Q&A
Keynote: 40–45 minutes

Workshop Presentation

• Workshops will focus on practical and advanced areas of dermatology, including dermoscopy, skin cancer screening, biopsy techniques, laser procedures, and digital dermatology.
• Interactive demonstrations and case-based learning will encourage practical knowledge development.
• Participants can explore modern diagnostic technologies and treatment approaches.
• Experts can demonstrate techniques and share valuable clinical experiences.
• Interdisciplinary participation will promote collaborative learning and professional development.

Duration: 45–50 minutes

Poster Presentation

• The poster presentation provides an opportunity to showcase original research, clinical studies, case reports, innovative treatments, and emerging technologies.
• It is particularly suitable for students, researchers, clinicians, and early-career professionals.
• Presenters can communicate their findings in a concise and visually engaging format.
• Participants can receive scientific feedback and interact directly with other researchers.
• The presentation also provides opportunities for networking and future research collaboration.

Presentation: 5–7 minutes including Q&A

Webinar Presentation

• Participants who cannot attend in person can contribute through an approved online or pre-recorded presentation.
• This format enables researchers and professionals from different countries to participate remotely.
• Presenters can share their research, clinical experiences, and innovative ideas with an international audience.
• It provides greater flexibility while maintaining scientific participation.
• Webinar presentations support global knowledge exchange and professional connectivity.

E-Poster Presentation

• E-Posters provide a convenient digital format for presenting research findings, case studies, clinical innovations, and emerging developments.
• Accepted presentations can reach participants through the conference's digital platform.
• Presenters can gain international visibility and receive feedback from professionals in the field.
• The format is particularly useful for researchers who prefer digital scientific communication.
• E-Poster participation also encourages networking and potential academic collaboration.

Advertisement

• Advertising in the DERMATOLOGY MEET 2027 program provides visibility among dermatologists, oncologists, researchers, clinicians, academicians, healthcare organizations, and industry professionals.
• It offers organizations an opportunity to promote their products, services, technologies, and institutional activities.
• Advertisements can help strengthen brand awareness within the international dermatology community.
• The conference provides a focused professional audience interested in medical and technological developments.
• Organizations can use this opportunity to increase recognition and establish new professional connections.

Sponsorship

• Sponsorship offers organizations valuable opportunities for branding, scientific recognition, exhibition participation, networking, and professional engagement.
• Sponsors can increase their visibility among international dermatology and healthcare professionals.
• It provides an opportunity to highlight innovative products, technologies, services, and research initiatives.
• Sponsorship also supports meaningful interaction with experts, researchers, and industry leaders.
• Organizations can strengthen their professional presence within the global dermatology community.

Past Conference

The 9th Annual Conference on Skin Cancer and Dermatology (DERMATOLOGY MEET 2026) was held on February 5–6, 2026, in Paris, France, bringing together dermatologists, researchers, clinicians, academicians, healthcare professionals, and industry representatives to exchange knowledge on skin cancer and modern dermatology. The scientific program covered melanoma, skin cancer diagnosis and treatment, dermato-oncology, dermatopathology, cosmetic dermatology, immunodermatology, skin infections, photodermatology, dermatologic surgery, teledermatology, and artificial intelligence in dermatology. The conference provided opportunities for oral presentations, poster presentations, e-posters, scientific exchange, networking, and international collaboration, encouraging participants to share research findings and explore emerging developments in dermatological care.

Upcoming Conference

Building on the success of the previous edition, DERMATOLOGY MEET 2027 will take place on April 12–13, 2027, in Dubai, UAE. The upcoming conference will bring together international experts to explore the latest advances in skin cancer prevention, early detection, diagnosis, treatment, precision medicine, immunotherapy, dermoscopy, dermatopathology, AI, digital dermatology, and personalized care.Under the theme “Advancing Skin Health Through Innovation, Precision, Prevention and Personalized Dermatological Care,” the conference will provide opportunities for research presentations, professional networking, knowledge exchange, scientific collaboration, and discussion of emerging technologies shaping the future of skin cancer and dermatology.